2nd Quarter - Report

FABIANI & COMPANY for ABLITECH, INC.

Period 2nd Quarter 2012 Filed Jul 19, 2012 Signed by Gary Martin, CFO

Official filing
Firm
FABIANI & COMPANY
Client
ABLITECH, INC.
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Development of therapeutics for the prevention of heterotopic ossification

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —

Contacted: Defense, Dept of (DOD)

Health Issues HCR

Development of therapeutics for the prevention of heterotopic ossification

LobbyistCovered position, as disclosed
ELIZABETH BARROWS —

Contacted: Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.